Overview

Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets medical devices and has a broad portfolio of products that addresses challenging medical conditions and significant clinical needs. Penumbra sells its products to hospitals and clinics primarily through its direct sales organization in the United States, most of Europe, Canada and Australia, and through distributors in select international markets. The Penumbra P logo is a trademark of Penumbra, Inc.

NYSE: PEN 120.45 -0.15 -0.12%
Volume: 126,434
Pricing delayed 20 minutes April 25, 2018 04:02 PM

SEC Filings

Date Filing Type Filing Description Download
Date March 29, 2018 Filing Type Form S-8 Filing Description Securities Registration: Employee Benefit Plan Download
Date March 19, 2018 Filing Type Form 4 Filing Description Statement of Changes in Beneficial Ownership Download
Date March 14, 2018 Filing Type Form 4 Filing Description Statement of Changes in Beneficial Ownership Download

IR Contact

investors@penumbrainc.com

Penumbra, Inc. Headquarters One Penumbra Place
Alameda, CA 94502
USA